Carnosine Inhibits Growth of Cells Isolated from Human Glioblastoma Multiforme
The present study evaluates the effect of the naturally occurring dipeptide carnosine on primary cell cultures established from patients with glioblastoma multiforme. Surgically removed tumors were used to establish primary cell cultures that were incubated for 96 h with medium supplemented with carnosine at concentrations of 20, 40 and 50 mM. Following incubation, dehydrogenase activity, cellular adenosine triphosphate concentration (ATP), caspase activity, lactate dehydrogenase (LDH) release and the rate of DNA synthesis were determined. After 96 h of carnosine treatment a significant reduction in cellular ATP and dehydrogenase activity was detected already at a concentration of 20 mM carnosine. Carnosine (50 mM) reduced ATP concentration to 42.7 ± 13.5% (n = 6) and dehydrogenase activity to 41.0 ± 19.3% (n = 6) compared to untreated cells. Additional experiments revealed no sign of enhanced apoptosis or necrosis in the presence of carnosine. However, a quantitative bromo-desoxy-uridine-based proliferation assay demonstrated a clear effect of carnosine on DNA synthesis reducing its rate down to 50% (2 cultures) and 10% (4 cultures). Therefore, it can be concluded that carnosine is obviously able to inhibit proliferation of cells derived from glioblastoma. Since it is a naturally occurring substance that appears to be non-toxic to normal tissue and is able to penetrate the blood–brain barrier it may be a candidate for a therapeutic agent that may reduce proliferation of neoplastic cells even in vivo and especially in cases of glioblastoma multiforme.
KeywordsHuman glioblastoma Carnosine Proliferation Cell-based assays
We would like to thank Mr. Baran-Schmidt for technical assistance in preparing the primary cultures of glioblastomas.
- Baran EJ (2000) Metal complexes of carnosine. Biochemistry (Mosc) 65:789–797Google Scholar
- Boldyrev AA (2000) Problems and perspectives in studying the biological role of carnosine. Biochemistry (Mosc) 65:751–756Google Scholar
- Gallant S, Semyonova M, Yuneva M (2000) Carnosine as a potential anti-senescence drug. Biochemistry (Mosc) 65:866–868Google Scholar
- Holliday R, McFarland GA (2000) A role for carnosine in cellular maintenance. Biochemistry (Mosc) 65:843–848Google Scholar
- Margolis FL (1980) Carnosine: an olfactory neuropeptide. In: Barker JL, Smith TG Jr (eds) The role of peptides in neuronal function. Marcel Decker, New York, pp 545–572Google Scholar
- Reddy VP, Garrett MR, Perry G, Smith MA (2005) Carnosine: a versatile antioxidant and antiglycating agent. Sci Aging Knowledge Environ 18:e12Google Scholar
- Scriver CR, Perry TL, Nutzenadel W (1983), In: Stanbury JB et al. (eds) The metabolic basis of inherited disease, 5th edn. McGraw-Hill, New York, pp 570–585Google Scholar
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRefGoogle Scholar